[
  {
    "ts": null,
    "headline": "Argus Research Upgrades McDonald's (MCD)",
    "summary": "Argus Research Upgrades McDonald's (MCD)",
    "url": "https://finnhub.io/api/news?id=2e4fd9e51beea589c6eaf7c0fa413c49002314435c7b94f49f2c6c781a82c2b6",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771277964,
      "headline": "Argus Research Upgrades McDonald's (MCD)",
      "id": 139117223,
      "image": "",
      "related": "MCD",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=2e4fd9e51beea589c6eaf7c0fa413c49002314435c7b94f49f2c6c781a82c2b6"
    }
  },
  {
    "ts": null,
    "headline": "McDonald's Tests High Protein Menu As GLP-1 Weight-Loss Drug Users Surge",
    "summary": "McDonald’s Corporation (NYSE:MCD) is adapting its menu as a growing number of Americans on GLP-1 weight-loss drugs, such as Ozempic and Wegovy, alter portion sizes, snacking habits, and beverage choices. McDonald's Tests High-Protein Options For GLP-1 Users During a Wednesday earnings call, CEO Chris Kempczinski said McDonald's is testing menu items to appeal to customers taking GLP-1 medications. \"As adoption grows, we know that consumers’ behavior changes,\" Kempczinski said. He noted these cus",
    "url": "https://finnhub.io/api/news?id=4527af1e6dad85a619f20250adf6f2cb39d1eb206952bf076fa995b63b2d0034",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771242369,
      "headline": "McDonald's Tests High Protein Menu As GLP-1 Weight-Loss Drug Users Surge",
      "id": 139113414,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCD",
      "source": "Yahoo",
      "summary": "McDonald’s Corporation (NYSE:MCD) is adapting its menu as a growing number of Americans on GLP-1 weight-loss drugs, such as Ozempic and Wegovy, alter portion sizes, snacking habits, and beverage choices. McDonald's Tests High-Protein Options For GLP-1 Users During a Wednesday earnings call, CEO Chris Kempczinski said McDonald's is testing menu items to appeal to customers taking GLP-1 medications. \"As adoption grows, we know that consumers’ behavior changes,\" Kempczinski said. He noted these cus",
      "url": "https://finnhub.io/api/news?id=4527af1e6dad85a619f20250adf6f2cb39d1eb206952bf076fa995b63b2d0034"
    }
  },
  {
    "ts": null,
    "headline": "The AI Market Crash Is Just Getting Started",
    "summary": "The AI Market Crash Is Just Getting Started",
    "url": "https://finnhub.io/api/news?id=865bbc2cf21a3cf9115284e36a7d83e359f44294fd23ecc9b4a30bb57964a7cb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771226100,
      "headline": "The AI Market Crash Is Just Getting Started",
      "id": 139113597,
      "image": "",
      "related": "MCD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=865bbc2cf21a3cf9115284e36a7d83e359f44294fd23ecc9b4a30bb57964a7cb"
    }
  },
  {
    "ts": null,
    "headline": "McDonald's 2026 Menu Shift Tests Growth Story For Valuation-Conscious Investors",
    "summary": "McDonald's (NYSE:MCD) plans major menu changes in 2026, including a nationwide rollout of new McCafé beverages. The company is introducing energy drink collaborations under the McCafé brand after strong test results. Limited-time promotions such as the McNugget Caviar kit have generated strong viral attention. McDonald's is also adjusting its food offering as more customers adopt GLP-1 weight loss medications. For you as an investor, these updates sit at the heart of what McDonald's does:...",
    "url": "https://finnhub.io/api/news?id=5e2dad549f2c1580d7000c71607c745af24071593c3f9ba7b39ec3eb868840b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771201098,
      "headline": "McDonald's 2026 Menu Shift Tests Growth Story For Valuation-Conscious Investors",
      "id": 139109345,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCD",
      "source": "Yahoo",
      "summary": "McDonald's (NYSE:MCD) plans major menu changes in 2026, including a nationwide rollout of new McCafé beverages. The company is introducing energy drink collaborations under the McCafé brand after strong test results. Limited-time promotions such as the McNugget Caviar kit have generated strong viral attention. McDonald's is also adjusting its food offering as more customers adopt GLP-1 weight loss medications. For you as an investor, these updates sit at the heart of what McDonald's does:...",
      "url": "https://finnhub.io/api/news?id=5e2dad549f2c1580d7000c71607c745af24071593c3f9ba7b39ec3eb868840b5"
    }
  }
]